The Avantage ® dual mobility cup in primary total hip arthroplasty: A registry study

Abstract

BackgroundAvantage Cup has been widely used in dual mobility implants. However, in Swedish Registry, the outcome of the Avantage Cup is reported with higher implants revision compared to control. The aim of our study was to verify if the same results are present in the Registry of Prosthetic Orthopedic Implants (RIPO) of Emilia Romagna (ER, Italy), as the Avantage cup was the most implanted dual mobility cup for a long follow-up reported in this Registry (2000–2012). Furthermore, we assessed the survival rate of the implant over the time. MethodsWe included all patients that underwent a primary THA using the Avantage cup during the period 2000–2020 in RIPO Registry. The survivorship of the primary THA implants was calculated and plotted according to Kaplan-Meier method. Results886 Avantage cups were included in the analysis. During the observational period 44 hips were revised. The most common reasons for revision were: periprosthetic fractures (PPF) (n = 7, 0.8 %), deep infection (n = 7, 0.8 %), and cup aseptic loosening (n = 13, 1.5 %).The survival rate of the implant was 96.8 % (95.3–97.8) at 5 years, 95.7 at 10 years (94.0–97.0) and 92.1 at 15 years (88.5–94.6). ConclusionIn conclusion, this study has demonstrated that the Avantage cup in primary hip arthroplasty implanted with a “friendly” femoral stem granted satisfactory long-term survival. Therefore, in the Swedish Registry, the cause of the poor results presented for Avantage Cup could be the thick, rough neck stem of the widely used Lubinus stem.